Briacell Therapeutics Corp. Common Shares (BCTX) is a publicly traded Healthcare sector company. As of August 24, 2026, BCTX trades at $3.95 with a market cap of $35.41M and a P/E ratio of -0.07. BCTX moved -2.95% today. Year to date, BCTX is -42.76%; over the trailing twelve months it is -37.85%. Its 52-week range spans $2.60 to $98.20. Rallies surfaces BCTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Briacell Therapeutics Corp. Common Shares (BCTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BCTX moved -2.95% today.
| Metric | Value |
|---|---|
| Price | $3.95 |
| Market Cap | $35.41M |
| P/E Ratio | -0.07 |
| EPS | $-62.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $98.20 |
| 52-Week Low | $2.60 |
| Volume | 7.23M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.56M |
| Gross Margin | 0.00% |
BCTX analyst coverage data. Average price target: $0.00.